GSW-28616-86261
4 vaccinations
7 coded responses
19 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Survey response — day 0, dose 1MedDRA: Pain in extremity — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Entire upper arm is soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-23
- 2021-01-30
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-21
-
2021-04-11
Survey response — 3 months, dose 2MedDRA: Fatigue — Feeling: GoodFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-11
-
2021-08-26
Dose 3 — Pfizer-BioNTech
-
2022-01-08
Survey response — 12 months, dose 2MedDRA: Fatigue, Intermenstrual bleeding, Menopause, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: cold like symptoms just 3 days break through menopause bleeding twice since 12/3 fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-10
-
2022-04-12
Dose 4 — Pfizer-BioNTech
-
2022-04-19
Survey response — day 7, dose 4MedDRA: No adverse event — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: noMedDRA releases: 2024-11 · check-in free text available
- 2022-04-26
- 2022-05-05
- 2022-05-12
- 2022-05-17
-
2022-10-13
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: i had covid September 11MedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-14
- 2022-10-14
-
2023-04-12
Survey response — 12 months, dose 4MedDRA: Cough, Dyspnoea, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-12
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-13
- 2023-04-13
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-08-26 | Pfizer-BioNTech | No |
| 4 | 2022-04-12 | Pfizer-BioNTech | No |
Call center
5 call center cases
3 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Entire upper arm is sore
Release 3 — day 28, dose 2
Symptoms: Fatigue
Release 7 — 3 months, dose 2
Symptoms: Fatigue
Release 10 — 12 months, dose 2
Symptoms: cold like symptoms just 3 days break through menopause bleeding twice since 12/3 fatigue
Release 11 — day 7, dose 4
Systemic reaction (other): no
Release 12 — 6 months, dose 4
Symptoms: i had covid September 11
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | · | · | ✓ |
| SD | Menopause | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release